Insider Transactions in Q2 2024 at Kiniksa Pharmaceuticals, Ltd. (KNSA)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 06
2024
|
Richard S Levy |
BUY
Exercise of conversion of derivative security
|
Direct |
4,373
+25.32%
|
-
|
|
Jun 06
2024
|
G Bradley Cole |
BUY
Exercise of conversion of derivative security
|
Direct |
4,373
+31.81%
|
-
|
|
Jun 06
2024
|
Barry D Quart |
BUY
Exercise of conversion of derivative security
|
Direct |
4,373
+31.81%
|
-
|
|
Jun 06
2024
|
Kimberly J Popovits |
BUY
Exercise of conversion of derivative security
|
Direct |
4,373
+31.81%
|
-
|
|
Jun 06
2024
|
Tracey L Mc Cain |
BUY
Exercise of conversion of derivative security
|
Direct |
4,373
+31.81%
|
-
|
|
Jun 06
2024
|
Thomas Malley |
BUY
Exercise of conversion of derivative security
|
Direct |
4,373
+31.81%
|
-
|
|
Jun 05
2024
|
Baker Bros. Advisors LP |
BUY
Grant, award, or other acquisition
|
Indirect |
12,692
+2.55%
|
-
|
|
May 03
2024
|
Richard S Levy |
BUY
Exercise of conversion of derivative security
|
Direct |
747
+8.06%
|
-
|
|
Apr 26
2024
|
Mark Ragosa CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
509
-2.58%
|
$8,653
$17.88 P/Share
|
|
Apr 26
2024
|
Mark Ragosa CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
991
+4.78%
|
-
|
|
Apr 08
2024
|
Mark Ragosa CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
791
-4.04%
|
$13,447
$17.9 P/Share
|
|
Apr 08
2024
|
Mark Ragosa CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
2,694
+12.1%
|
-
|
|
Apr 08
2024
|
John F. Paolini CHIEF MEDICAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
733
-1.51%
|
$12,461
$17.9 P/Share
|
|
Apr 08
2024
|
John F. Paolini CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
2,497
+4.89%
|
-
|
|
Apr 08
2024
|
Sanj K Patel CHAIRMAN & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,075
-6.07%
|
$69,275
$17.9 P/Share
|
|
Apr 08
2024
|
Sanj K Patel CHAIRMAN & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
9,992
+12.96%
|
-
|
|
Apr 08
2024
|
Eben Tessari CHIEF OPERATING OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
801
-0.63%
|
$13,617
$17.9 P/Share
|
|
Apr 08
2024
|
Eben Tessari CHIEF OPERATING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
2,726
+2.1%
|
-
|
|
Apr 08
2024
|
Michael R Megna CHIEF ACCOUNTING OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,666
-7.25%
|
$28,322
$17.9 P/Share
|
|
Apr 08
2024
|
Michael R Megna CHIEF ACCOUNTING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
3,932
+14.6%
|
-
|
|
Apr 08
2024
|
Ross Moat CHIEF COMMERCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,353
-7.67%
|
$23,001
$17.9 P/Share
|
|
Apr 08
2024
|
Ross Moat CHIEF COMMERCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
2,477
+12.32%
|
-
|
|
Apr 01
2024
|
Mark Ragosa CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
514
-2.96%
|
$9,766
$19.7 P/Share
|
|
Apr 01
2024
|
Mark Ragosa CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,750
+9.15%
|
-
|
|
Apr 01
2024
|
Ross Moat CHIEF COMMERCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
880
-5.49%
|
$16,720
$19.7 P/Share
|
|
Apr 01
2024
|
Ross Moat CHIEF COMMERCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,612
+9.14%
|
-
|
|
Apr 01
2024
|
Michael R Megna CHIEF ACCOUNTING OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,084
-5.38%
|
$20,596
$19.7 P/Share
|
|
Apr 01
2024
|
Michael R Megna CHIEF ACCOUNTING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
2,558
+11.27%
|
-
|
|
Apr 01
2024
|
Sanj K Patel CHAIRMAN & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,903
-3.23%
|
$36,157
$19.7 P/Share
|
|
Apr 01
2024
|
Sanj K Patel CHAIRMAN & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
6,482
+9.9%
|
-
|
|
Apr 01
2024
|
Eben Tessari CHIEF OPERATING OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
521
-0.42%
|
$9,899
$19.7 P/Share
|
|
Apr 01
2024
|
Eben Tessari CHIEF OPERATING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,773
+1.4%
|
-
|
|
Apr 01
2024
|
John F. Paolini CHIEF MEDICAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
477
-1.03%
|
$9,063
$19.7 P/Share
|
|
Apr 01
2024
|
John F. Paolini CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,624
+3.37%
|
-
|